Result of Retail Offer and Total Voting Rights
Scancell Holdings plc has successfully completed an oversubscribed Retail Offer, raising gross proceeds of £2.7 million at an issue price of 9 pence per share, resulting in the issuance of 30,004,836 new Ordinary Shares. This Retail Offer, along with the UK Placing, has collectively raised approximately £15.7 million for the company. Admission of these new shares to AIM is expected on or around July 28, 2026, at which point the company's total issued ordinary share capital will be 1,212,230,683 Ordinary Shares.
Select text to share a quote on X · sign in to keep highlights & notes in your SCLP notes
Scancell Holdings plc (AIM: SCLP), a late-stage clinical immuno-oncology company developing active immunotherapies designed to enhance anti-tumour immune responses in difficult-to-treat cancers, is pleased to confirm, further to the announcements made on 23 July 2026, the result of its significantly oversubscribed Retail Offer raising gross proceeds of £2.7 million (c.$3.6 million) at the Issue Price of 9 pence per share. Accordingly, the Company will issue a total of 30,004,836 new Ordinary Shares at the Issue Price pursuant to the Retail Offer.
The Launch of Retail Offer announcement released by the Company on 23 July 2027 detailed a retail offer via the Winterflood Retail Access Platform ("WRAP") to raise up to £2.3 million (c.$3.0 million) (before expenses). As a result of significant demand in the Retail Offer and the board of Scancell's desire to provide additional support for the Company's balance sheet, the Company modestly increased the size of the Retail Offer to £2.7 million (c.$3.6 million) with allocations scaled back due to the level of investor demand with preference towards existing shareholders of the Company.
In aggregate, the UK Placing and the Retail Offer have raised gross proceeds of approximately £15.7 million (c.$21.0 million) for the Company, via the Placing of 144,444,444 Placing Shares and the 30,004,836 Retail Offer Shares.
Admission and Total Voting Rights
An application has been made to London Stock Exchange plc for the Placing Shares and the Retail Offer Shares to be admitted to trading on AIM ("Admission"). It is expected Admission will become effective and dealings in the new Ordinary Shares will commence at 8:00 a.m. on or around 28 July 2026. The UK Placing and Retail Offer are conditional upon, among other things, Admission becoming effective.
Upon Admission, the Company's issued ordinary share capital will consist of 1,212,230,683 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, from Admission the total number of Ordinary Shares and voting rights in the Company will be 1,212,230,683. With effect from Admission, this figure may be used by Shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
The new Ordinary Shares to be issued pursuant to the Retail Offer will be issued free of all liens, charges and encumbrances and will, on Admission, rank pari passu in all respects with the new Ordinary Shares to be issued pursuant to the UK Placing and the Company's existing Ordinary Shares.
Capitalised terms used in this announcement have the meaning as defined in the US Listing Transaction Announcement and the Retail Offer Launch Announcement unless otherwise stated.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.